MX6223E - Procedimiento mejorado para la preparacion de provectiles balisticos que contienen una composicion biologicamente activa - Google Patents

Procedimiento mejorado para la preparacion de provectiles balisticos que contienen una composicion biologicamente activa

Info

Publication number
MX6223E
MX6223E MX819684U MX968481U MX6223E MX 6223 E MX6223 E MX 6223E MX 819684 U MX819684 U MX 819684U MX 968481 U MX968481 U MX 968481U MX 6223 E MX6223 E MX 6223E
Authority
MX
Mexico
Prior art keywords
provectiles
ballistic
preparation
biologically active
active composition
Prior art date
Application number
MX819684U
Other languages
English (en)
Inventor
James F Drake
George Phillip Rambosek
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of MX6223E publication Critical patent/MX6223E/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F42—AMMUNITION; BLASTING
    • F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
    • F42B12/00—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material
    • F42B12/02—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect
    • F42B12/36—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information
    • F42B12/46—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information for dispensing gases, vapours, powders or chemically-reactive substances
    • F42B12/54—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information for dispensing gases, vapours, powders or chemically-reactive substances by implantation, e.g. hypodermic projectiles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Combustion & Propulsion (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
MX819684U 1980-09-30 1981-09-30 Procedimiento mejorado para la preparacion de provectiles balisticos que contienen una composicion biologicamente activa MX6223E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/192,297 US4326524A (en) 1980-09-30 1980-09-30 Solid dose ballistic projectile

Publications (1)

Publication Number Publication Date
MX6223E true MX6223E (es) 1984-12-21

Family

ID=22709096

Family Applications (1)

Application Number Title Priority Date Filing Date
MX819684U MX6223E (es) 1980-09-30 1981-09-30 Procedimiento mejorado para la preparacion de provectiles balisticos que contienen una composicion biologicamente activa

Country Status (8)

Country Link
US (1) US4326524A (es)
EP (1) EP0049068B1 (es)
AR (1) AR229104A1 (es)
AU (1) AU539016B2 (es)
CA (1) CA1138333A (es)
DE (1) DE3173140D1 (es)
MX (1) MX6223E (es)
NZ (1) NZ198494A (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
GB8514666D0 (en) * 1985-06-11 1985-07-10 Coopers Animal Health Agent delivery systems
EP0265457A4 (en) * 1986-04-10 1989-07-26 Daratech Pty Ltd VACCINE AND IMPLANT.
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
NL9002215A (nl) * 1990-10-11 1992-05-06 Texas Instruments Holland Werkwijze voor het inbrengen van een transponder samen met een desinfecterend middel alsmede dit middel.
FR2673843B1 (fr) * 1991-03-14 1995-01-13 Centre Nat Rech Scient Composition pharmaceutique implantable, bioresorbable a base de poly(acide lactique), destinee a mettre en óoeuvre une antibiotherapie interne locale.
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6673335B1 (en) * 1992-07-08 2004-01-06 Nektar Therapeutics Compositions and methods for the pulmonary delivery of aerosolized medicaments
ES2179831T3 (es) * 1992-09-29 2003-02-01 Inhale Therapeutic Syst Liberacion en los pulmones de fragmentos activos de hormona paratiroidiana.
EP1462096B1 (en) * 1994-03-07 2008-12-10 Nektar Therapeutics Methods and compositions for pulmonary delivery of insulin
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
CN1073119C (zh) * 1994-05-18 2001-10-17 吸入治疗系统公司 干扰素干粉配方的方法及组合物
US5785680A (en) * 1994-06-13 1998-07-28 Texas Instruments Incorporated Injector and object to be injected by the injector
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
US5837276A (en) * 1994-09-02 1998-11-17 Delab Apparatus for the delivery of elongate solid drug compositions
US5595973A (en) 1994-09-12 1997-01-21 Biomeasure Incorporated Protection of hemopoietic cells during chemotherapy or radiotherapy
US5542920A (en) 1994-09-12 1996-08-06 Delab Needle-less parenteral introduction device
AU3634595A (en) * 1994-09-16 1996-03-29 Angus Chemical Company Bis-oxazolidines and their use
US20030035778A1 (en) * 1997-07-14 2003-02-20 Robert Platz Methods and compositions for the dry powder formulation of interferon
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
DE60003803T2 (de) 1999-04-16 2004-06-03 Novo Nordisk A/S Trockene formbare arzneistoffformulierung
DE19946059A1 (de) * 1999-09-25 2001-03-29 Roche Diagnostics Gmbh System zur transdermalen Gewinnung von Körperflüssigkeit
EP1229885B1 (en) 1999-10-13 2004-05-19 Novo Nordisk A/S Method for producing an elongated drug formulation
US6454759B2 (en) * 2000-02-28 2002-09-24 The Regents Of The University Of California Microfabricated injectable drug delivery system
AU2001247369A1 (en) 2000-03-10 2001-09-24 Washington University Method for labeling individual cells
US6375971B1 (en) 2000-04-28 2002-04-23 Ballistic Technologies, Inc. Medicament dosing ballistic implant of improved accuracy
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
WO2002009674A2 (en) * 2000-07-28 2002-02-07 Inhale Therapeutic Systems, Inc. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
GB2404865B (en) * 2001-09-11 2005-09-28 Caretek Medical Ltd Novel drug delivery technology
US7615234B2 (en) 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
CA2474292A1 (en) * 2002-01-24 2003-07-31 Smart Drug Systems Inc Sustained release pharmaceutical composition
US20030159612A1 (en) * 2002-02-28 2003-08-28 Terrance Ziemack Ballistic implant system and methods
GB2421689B (en) * 2002-08-05 2007-03-07 Caretek Medical Ltd Drug delivery system
GB2422784A (en) * 2005-02-07 2006-08-09 Caretek Medical Ltd Disposable assembly comprising a needle or stylet
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
GB0612020D0 (en) * 2006-06-16 2006-07-26 Brydges Price Richard I Projectile for administering a medicament
US7392746B2 (en) * 2006-06-29 2008-07-01 Hansen Richard D Bullet composition
GB2446780A (en) 2007-02-22 2008-08-27 Glide Pharmaceutical Technolog An elongate parenteral injection body having an injection point of angle 10 to 40 degrees.
AU2014253541B2 (en) * 2007-02-22 2016-07-28 Glide Pharmaceutical Technologies Limited Solid pharmaceutical and vaccine dose
WO2008105663A1 (en) * 2007-03-01 2008-09-04 Bioneedle Technologies Group B.V. Implant containing destructurized starch
EP2115008B1 (en) * 2007-03-01 2019-09-18 De Staat der Nederlanden, vert. door de Minister van Volksgezondheid, Welzijn en Sport, namens de Minister, Projectdirectie ALT, het INTRAVACC Biodegradable material based on opened starch
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
GB201317641D0 (en) 2013-10-05 2013-11-20 Chowdhury Dewan F H Novel solid dosage form
US10039885B2 (en) 2015-02-09 2018-08-07 Palo Alto Research Center Incorporated System and method for enhancing particle delivery to biological tissue
US10449297B2 (en) 2015-02-09 2019-10-22 Palo Alto Research Center Incorporated Alignment of elongated particles in a particle delivery device
EP3623742B1 (en) * 2018-09-14 2023-08-02 Jonas Rudolf Michael Weiss Net launcher
US11583500B2 (en) * 2018-11-11 2023-02-21 Benjamin Baldwin System for remote administering of medical chemicals to unrestrained animals
KR102181636B1 (ko) * 2019-11-06 2020-11-23 포항공과대학교 산학협력단 고체 발사체 제작방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2574597A (en) * 1949-03-03 1951-11-13 Celanese Corp Spray-dried dyestuff powders comprising lignin sulfonate
US3166476A (en) * 1961-09-01 1965-01-19 Lowey Hans Powder based tablets
US3362880A (en) * 1963-09-20 1968-01-09 Dow Chemical Co Compressed drug tablets of ethyl cellulose, glyceryl monostearate, karaya gum, tragacanth, talc, and magnesium stearate
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant
US3619292A (en) * 1968-07-15 1971-11-09 Penick & Ford Ltd Tablets and method of forming
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US3629393A (en) * 1969-09-11 1971-12-21 Nikken Chemicals Co Ltd Release-sustaining-tablet
US3632739A (en) * 1969-12-29 1972-01-04 Sandoz Ag Solid sustained release pharmaceutical preparation
US3690034A (en) * 1971-03-08 1972-09-12 Aptek Ind Inc Environmental seed cell
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3774607A (en) * 1971-11-22 1973-11-27 Commercial Solvents Corp Pellet implant gun
US3800038A (en) * 1972-04-21 1974-03-26 Biolog Concepts Inc Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier
US3948263A (en) * 1974-08-14 1976-04-06 Minnesota Mining And Manufacturing Company Ballistic animal implant
US3982536A (en) * 1974-11-15 1976-09-28 Minnesota Mining And Manufacturing Company Ballistic inoculation of animals and projectile therefor
US3991750A (en) * 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
CA1076480A (en) * 1975-04-28 1980-04-29 John S. Kent Inert core implant pellet
DE2747570A1 (de) * 1976-11-10 1978-05-18 Minnesota Mining & Mfg Geschoss

Also Published As

Publication number Publication date
AR229104A1 (es) 1983-06-15
NZ198494A (en) 1985-08-30
AU539016B2 (en) 1984-09-06
AU7573981A (en) 1982-04-08
CA1138333A (en) 1982-12-28
EP0049068B1 (en) 1985-12-04
US4326524A (en) 1982-04-27
DE3173140D1 (en) 1986-01-16
EP0049068A1 (en) 1982-04-07

Similar Documents

Publication Publication Date Title
MX6223E (es) Procedimiento mejorado para la preparacion de provectiles balisticos que contienen una composicion biologicamente activa
BR8107839A (pt) Processo para a preparacao de um composto biologicamente ativo
ES492676A0 (es) Un procedimiento para la preparacion de composiciones lipo- somicas de substancias activas grasosolubles
ES547738A0 (es) Un procedimiento para la preparacion de una composicion terapeutica que contiene un fosfato de dialquilo.
ES547478A0 (es) Procedimiento para la preparacion de pelicula de celulosa
ES518879A0 (es) Un procedimiento para la preparacion de una composicion termoplastica cargada.
ES490018A0 (es) Un procedimiento para la preparacion de una nueva composi- cion de copolieterester.
ES493986A0 (es) Un procedimiento para la preparacion de una mezcla hidrocar-burada
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
ES502676A0 (es) Un procedimiento para la preparacion de una composicion ter-moplastica transparente
ES504741A0 (es) Un procedimiento para la preparacion de una composicion esporicida de dialdehido-diol.
ES496019A0 (es) Procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo
ES500897A0 (es) Un procedimiento para la preparacion de una mezcla de hidro-carburos
ES493596A0 (es) Un procedimiento para la preparacion de una composicion ten soactiva.
AR222384A1 (es) Composicion util para la preparacion de una solucion de control de bilirrubina
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
AR227697A1 (es) Procedimiento para la preparacion de 3,4-bis-sustituido 1,2,5,-oxadiazol-2-oxidos
ES500618A0 (es) Procedimiento para la preparacion de 2,3-dicloro-2-trifluo- rometil-1,1,1,3,4,4,5,5,5,-nonafluoropentano
MX7052E (es) Procedimiento para la preparacion de 2-metoxi-4-amino-5-alquilsulfonil-n-(3-beta-8-azabiciclo-(3,2,1)octil)-benzamidas
ES502120A0 (es) Procedimiento para la preparacion de compuestos de viniles- tilbeno
MX6936E (es) Procedimiento para la preparacion de compuestos derivados de triazol
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas